Charles Rowland Jr Net Worth & Insider Trades
Charles Rowland Jr - Director, Viking Therapeutics, Inc
What is Charles Rowland Jr's Net Worth?
The current estimated net worth of Viking Therapeutics, Inc's Director, Charles Rowland Jr, is estimated to be about $5.01M . Charles Rowland Jr owns about 30,000 units of Viking Therapeutics, Inc common stock. In the last 6 years at Viking Therapeutics, Inc, Charles Rowland Jr has sold an estimated value of $1M worth.
What is Charles Rowland Jr's Past Insider Trading?
Charles Rowland Jr's largest purchase order was 30,000 units , worth over $154.8K on May 31, 2018. Charles Rowland Jr's largest sale order was 40,000 units , worth over $1M on May 18, 2023. In total, Charles Rowland Jr has made about 9 transactions over 6 years of their time at Viking Therapeutics, Inc. Charles Rowland Jr usually trades in January, with the busiest year in 2018 and 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Charles Rowland Jr
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Charles Rowland Jr's' Mailing Address?
- Mailing address is 3338 Lancashire Rd Furlong PA 18925 PA
Viking Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Brian Lian, Ph.D. | 2020 | $577,000 | $301,000 | $2,485,102 | $1,824,346 | - | $5,187,448 |
| Brian Lian, Ph.D. | 2019 | $525,000 | $210,000 | $1,530,379 | $1,246,740 | - | $3,512,119 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1607678/000156459021018175/vktx-def14a_20210520.htm
What are Viking Therapeutics, Inc's Past Insider Trades?
Viking Therapeutics, Inc's most recent insider trade came on May 18, 2023 by Charles Rowland Jr who sold 40,000 units worth $1M . In the last 8 years, insiders at Viking Therapeutics, Inc have sold an estimated value of $37.43M and bought an estimated value of $6.67M worth of shares. Insider trading is most common in January, with the busiest year in 2023. The most active traders at the company are Brian Lian, President & CEO, Michael Morneau, VP, and Matthew Foehr, Director .
Viking Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||